The BSI Team
Tom Lally, 65, is President, a Director and Chief Technology Officer. Working through his company, Bindan Corporation ("Bindan"), Lally originally invented a binder for highway paving. On further investigation of applications of this patented adhesive property, the technology evolved into a medical application. Lally was awarded the original patent for the BSI technology and this was assigned to Bone Solutions, Inc..
Tony Copp, Ph.D. (Economics), 62, is COO, a Director and leads in funding and strategic planning efforts. He was a former V.P., Manager of the Petroleum Group at Salomon Brothers in New York, NY. Following his time with Salomon Brothers, Copp became Vice President of Corporate Finance for Ray Hunt's enterprises, largely Hunt Oil Company, the world's largest independent oil Company for 17 years. Forming Copp Ventures in 1997, Copp has worked with John Albers, previous BSI Chairman and CEO who passed away in late 2008, on a blood container device for military uses for a Company named Thermo Solutions and is presently a Consultant for a medical imaging company. He has raised over $2 billion in his finance career.
Drew Diaz, 45, is a Director, with a focus on sales, marketing for BSI worldwide. Mr. Diaz is currently CEO of Heart Test Laboratories, of Colleyville, TX. He was previously the Senior Vice President of World Wide Sales and an officer for Criticare Systems Inc., a publicly held US-based manufacturer of medical monitoring instruments that designs, manufactures and markets vital signs and gas monitoring instruments and related noninvasive sensors used to monitor patients in many healthcare environments. Criticare was recently acquired by Opto Circuits, LTD of India. Prior to Criticare systems, Mr. Diaz worked for Strato Medical (Pfizer's implant division), organizing and managing a distributor network for the Southwest US region, based in Dallas, Texas. He has also been District Sales Manager for DeRoyal Industries, covering the Texas market for operating room disposables.
Jim McNamara, 67, is Treasurer, Secretary, and a Director, as well as a shareholder in Bindan Corporation. He is responsible for the financial, accounting, treasury functions, secretarial functions and budget planning of BSI. He has been Director of Marketing at Telular Corporation, a publicly held company. He was an Executive for the IBM Corporation in marketing, and was Director of Finance and Planning for the IBM Marketing Group and Planning for IBM Europe.
Wade Hampton, Director, has extensive national and international medical device sales experience. Mr. Hampton, is currently Senior Vice President of Worldwide Sales for Accuray, Inc., the manufacturer of CyberKnife, a robotic radiosurgery system used for non-surgical treatment of cancer tumors throughout the body. Prior to Accuray, Mr Hampton was Senior Vice President of the Americas for Lumenis Inc., the world's largest manufacturer of medical lasers. Mr. Hampton has also worked at Coherent Medical and Johnson & Johnson.
Dr. Alicia L. Bertone, D.V.M., is Chairman of the Scientific Advisory Board. Dr. Bertone has led the research studies for BSI on OsteoCrete™, developed the key research papers for presentation at ORS/AAOS meetings, and has been coordinating with NAMSA on the FDA protocol testing for BSI’s bone void filler. She has also been a keynote speaker for BSI at several venture capital forums. Dr. Bertone is Professor of Orthopedic Surgery at Ohio State University, and the Trueman Chair of Orthopedics. She is a member of the American College of Veterinarian Surgery, and completed a recent fellowship at Harvard University in molecular orthopedics and gene therapy. She has published over 200 scientific papers, and has given technical presentations most recently at the 2004, 2005 and 2006 ORS/AAOS meetings.
Phil Holcombe, Director. Mr. Holcombe brings a strong background in the fields of Oral/Maxillofacial Surgery & Implants. From 1990 to 2007, he has been Owner and President of Pro Med Sales, Inc. a dental & surgical equipment company engaged in the design of ambulatory surgical facilities with a focus on Oral/Maxillofacial. He has also been National Sales Manger (USA) of Trophy Radiology, a leading manufacturer in the rapidly expanding use of digital radiology in dental Implants. Trophy manufactured the first digital x-ray system for use in dentistry. Mr. Holcombe also worked for Cambiare Ltd. and McKesson Co. in the dental industry.
Raymond Leonard Warpeha, M.D., D.D.S., PH.D., is Professor Emeritus, Department of Surgery, Division of Plastic and Reconstructive Surgery, Loyola University Medical Center, Maywood, IL. He has been Professor of Surgery and Anatomy, at the Loyola Stritch School of Medicine, a Consultant and Chief of Division of Plastic Surgery, at the Hines VA Hospital, Hines, IL., and Chairman of the Division of Plastic and Reconstructive Surgery at Loyola. His academic and medical doctorates are from Northwestern University, and his DDA is from the University of Minnesota, Minneapolis, MN. He is a Trustee of the American Society of Maxillofacial Surgeons, and former President of the Chicago Society of Plastic Surgery. He is a Founder and Director of the Burn Center, Loyola University Hospital and a professional lecturer in anatomy at Northwestern University Medical School, Chicago, IL.
Other members of the Scientific Advisory Committee are major players in their own field of expertise and are listed as follows:
Dr. Nancy Lynch, Principal of Scale Venture Partners, Foster City, CA, a major medical venture investing company;
Dr. Richard Steadman head of the Steadman-Hawkins Clinic in Vail, Colorado and world famous for his knee surgery expertise;
Dr. Thomas Wilson, Dallas, TX, a leading periodontist in the industry and author of graduate student books on periodontics. He is coordinating current research at the University of Texas at San Antonio Dental School in testing OsteoCrete™ as a adhesive dental implant;
Dr. James B. Montgomery, head of Orthopedic Specialists in Dallas, Texas and a sports medicine specialist;
Dr. Tarek Souryal, head of the Texas Sports Medicine Clinic and chief physician for the Dallas Mavericks professional basketball team;
Dr. Mike Pikos, head of the MAP Implant Institute, and a world expert on dental implants, Palm Harbor, FL;
Dr. John Russo, international lecturer and global expert on dental implants and oral surgery, Sarasota, FL;
Dr. Edward Mills, director of the Atlanta Center for Restorative Dentistry, Atlanta, GA.
Dr. Scott Rodeo of the Hospital for Special Surgery in New York, NY, has been a member of the BSI Advisory Board, but to eliminate any potential conflict voluntarily resigned to be free to develop and pursue specific research projects using the BSI technology. Dr. Rodeo participated in the poster presentation at the 2008 ORS/AAOS meetings on his research with BSI technology and this presentation has also been published in the American Journal of Sports Medicine relating to the adhesive qualities of OsteoCrete™ for publication in 2008.
Mr. R.C. Trahan of Ronald Trahan Associates, Inc. Boston, Massachusetts (www.ronaldtrahan.com) has been retained to be the Company public relations firm. Trahan has assisted the Company in its access to national forums before industry partners and financing sources. TECSA of Santa Barbara, California is working with the company to write up its CE Mark application, FDA applications, and other Quality Manual documentation needed for these purposes.
Legal Resources: Legal representation for BSI includes Dallas based Bellinger & DeWolf LLP,(www.bd-law.com) and, Wilson Sonsini Goodrich & Rosati, (www.wsgr.com) the nation’s leading life sciences venture representation firm, with offices in Palo Alto, CA and across the country. McDonnell Boehnen Hulbert & Berghoff LLP of Chicago, Illinois (www.mbhb.com ) was retained in 2005 as the Company's Patent/Intellectual Property attorneys.
Other Marketing/Sales Personnel: BSI will initiate the process of interviewing several individuals who will be considered as the initial core sales managers for its product lines reporting to an Senior VP for Sales and Marketing. Their primary responsibilities will be to introduce the products into key markets, and/or to work with the leading doctors in their respective fields and as appropriate designated distributors to help introduce the product into markets, or to work with a Joint Venture partner (not yet defined) and its staff to use the product successfully.